Briefly summarized, embodiments of the present invention are directed to a patency device for catheter assemblies and other elongate tubular devices used for establishing access to an interior body portion of a patient. The patency device establishes and/or preserves patency of one or more lumens defined by the catheter assembly by providing impulses of positive pressure to fluid disposed in the lumen of the catheter assembly.
In one embodiment, the patency device comprises a fluid reservoir configured to provide a fluid (or establish a fluid path) to at least one lumen of the catheter assembly, and a pressure input portion. The pressure input portion is configured to provide pressure for one or more impulses of positive pressure to a fluid disposed within the lumen. The impulses are configured to dislodge occlusions that may have formed in the lumen. A negative pressure can then be provided to the lumen to aspirate the occlusion and remove it from the catheter assembly.
These and other features of embodiments of the present invention will become more fully apparent from the following description and appended claims, or may be learned by the practice of embodiments of the invention as set forth hereinafter.
A more particular description of the present disclosure will be rendered by reference to specific embodiments thereof that are illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. Example embodiments of the invention will be described and explained with additional specificity and detail through the use of the accompanying drawings in which:
Reference will now be made to figures wherein like structures will be provided with like reference designations. It is understood that the drawings are diagrammatic and schematic representations of exemplary embodiments of the present invention, and are neither limiting nor necessarily drawn to scale.
For clarity it is to be understood that the word “proximal” refers to a direction relatively closer to a clinician using the device to be described herein, while the word “distal” refers to a direction relatively further from the clinician. For example, the end of a catheter placed within the body of a patient is considered a distal end of the catheter, while the catheter end remaining outside the body is a proximal end of the catheter. Also, the words “including,” “has,” and “having,” as used herein, including the claims, shall have the same meaning as the word “comprising.”
Embodiments of the present invention are generally directed to catheter assemblies and other elongate tubular devices used for establishing access to an interior body portion of a patient. A peripherally inserted central catheter (“PICC”) is one example of such a catheter assembly. In particular, solutions and methods for establishing and preserving the patency of one or more lumens defined by the catheter assembly are disclosed. Examples of patency devices that may be employed are disclosed according to particular embodiments, discussed below.
Reference is first made to
Though shown here as defining a single lumen 14, the catheter 10 in other embodiments can define two or more lumens. Also, though shown as a PICC, the catheter in other embodiments can include other catheter types, such as dialysis, CVC, PIV, urinary, arterial, balloon catheters, etc. Thus, the discussion herein is not intended to be limiting.
In greater detail, the pressure input portion 38 of the patency device 30 includes a mechanical input, such as a manual or motor-controlled plunger-type syringe, to impart pressure impulses to fluid contained in the fluid reservoir 34. The fluid reservoir 34 is configured to hold an amount of fluid that can be directed into the lumen(s) 14 of the catheter tube 12 prior to or in conjunction with the pressure impulses produced by the pressure input portion 38. In one embodiment and as seen below, the fluid reservoir 34 serves as a hydraulic accumulator to store pressurized fluid, produced by the pressure input portion 38, before its release to the lumen(s) 14.
It is noted that other types of pressure input portions can be utilized to provide high-pressure fluid impulses, including electrical and acoustic actuators, voice coil actuators, linear actuators, piezoelectric motors, vibrational drums and membrane, etc., for instance.
A catheter connector interface 40 defining a lumen 42 is included to enable the patency device 30 to operably connect to the luer connector 22 (or other portion) of the catheter 10 and provide a conduit through which the high pressure fluid can pass from the fluid reservoir 34 to the lumen(s) 14 of the catheter tube 12. Note that in one embodiment the connector interface 40 is a sterile item to bridge between the non-sterile patency device 30 and the catheter 10. In this way, the connector interface 40 can be manufactured as a disposable, sterile item, while the patency device 30 is reusable.
In operation, the patency device 30 emits periodic, relatively short-duration, relatively high-pressure bursts, or impulses, in the distal direction through the fluid-filled lumen 14 of the catheter tube 12. These impulses are produced by the pressure input portion 38 in conjunction with the pressure portion 34 and transmitted through the lumen 42 of the patency device 30 to the catheter tube lumen 14 via the connector interface 40 luer connector 22. It is appreciated that the pressure of the impulses, the impulse duration, the rest period between impulses, the frequency of successive impulses, etc., can be adjusted and varied according to the particular patency procedure being performed for the catheter 10.
In one embodiment, the pressure peaks 82 are modified by a controller of the patency device 30 so as to be customizable by the user. The rest periods 84 between the high-pressure fluid impulses (represented by the pressure peaks 82) can also be varied in duration, baseline pressure, etc.
In the present embodiment, the maximum pressure achieved by the impulses is about 400 psi, though this can vary according to desired application, catheter lumen design, type or size of occlusion, catheter tube length, etc. In one embodiment, it is appreciated that the maximum pressure of the impulses may exceed the burst pressure strength rating of the catheter tube 12 in one embodiment, but as the impulses are of relatively short duration, no rupturing or failure of the catheter 10 occurs.
As mentioned above, the high-pressure fluid impulses travel from the patency device 30 and into the catheter 10 so as to travel down the fluid-filled lumen 14 of the catheter tube 12. In one embodiment, the fluid filling the fluid path of the patency device and the catheter tube lumen 14 is a 0.9% saline solution, though other fluids may also be acceptably used. Note that the use of other fluids can necessitate altering the impulse characteristics (e.g., impulse pressure, impulse duration, rest period duration, etc.). As noted above, the high-pressure fluid impulses impinge on an occlusion (such as a clot or fibrin sheath) or other obstruction that has formed in the lumen 14, typically at or proximate the distal end 12B of the catheter tube 12. The occlusion is dislodged by the high-pressure impulses, which are strong enough to dislodge the occlusion but are not of sufficient duration to push it out the distal end 12B of the catheter tube 12. The subsequent negative pressure rest period following each impulse can act to prevent escape of the clot from the catheter tube 12, in one embodiment. In addition, a suction process can be performed by the patency device 30 to withdraw the clot proximally from the catheter tube 12 and catheter 10 and into the patency device, where it may be disposed of. In this way, any clot or occlusion present in the catheter 10 can be acceptably removed.
A two-way, normally open (“N.O.”) valve 150 is interposed between the N.C. valve 140 and the transducer 144 via a fluid line connected to the N.O. valve fluid inlet. A vacuum input portion 160 for providing negative pressure in the patency device 30 is operably connected to the fluid outlet of the N.C. valve 150. In the present embodiment, a syringe pump 162 serves as the vacuum input portion 160, though other suitable components can also be employed, such as a vacuum pump. A controller 170 is operably connected to the aforementioned components of the patency device 30 to govern their operation. The controller 170 in one embodiment includes a power source, a printed circuit board including a processor, etc.
The patency device 30 of
The controller 170 determines the number, frequency, rest periods, etc., of the impulses to be delivered by the patency device 30 to the catheter tube lumen(s) 14. The N.C. valve 140 is opened and close repeatedly at predetermined time intervals to provide a series of fluid impulses from the accumulator, through the N.C. valve and into the lumen 14 of the catheter 10. During each impulse when the N.C valve 140 is opened, the N.O valve 150 is shut so as to prevent impulse fluid from entering the N.O. valve and diverting to the syringe pump 162 instead of entering the catheter tube lumen 14 as desired. The impulses are propagated distally down the lumen 14, which is fluid-filled prior to commencement of the patency operation so as to provide a propagation medium for the impulses.
Between each impulse and after the series of impulses has ended, the N.C. valve 140 closes and the N.O. valve 150 opens to provide a negative baseline pressure (provided by the syringe pump 162 or other suitable device) in the catheter tube lumen 14 and enable any occlusion dislodged by the impulses to be suctioned proximally out of the lumen, through the N.O. valve to the syringe pump 162. An appropriate capture reservoir or the like can be operably connected to the syringe pump to provide for retention of occlusions and fluid if needed. The controller 170 is utilized to precisely control the opening/closing of the N.C. valve 140 and the N.O. valve 150 so as to provide the impulses and the negative baseline pressure to the lumen 14 as desired.
In one embodiment, it is appreciated that the baseline negative pressure periods existing between the positive pressure impulses can be replaced or supplemented with relatively short-duration impulses of negative pressure to further assist in occlusion dislodgement. Subsequent negative baseline pressure can then be used to remove the occlusion to the lumen 14. In one embodiment, the response time of the valves 140 and 150 is sufficiently fast to enable the positive pressure impulses to be followed in quick succession by the negative baseline pressure or negative pressure impulse.
The pressure transducer 144 is utilized and controlled by the processor 170 to measure the pressure of the impulses delivered to the catheter tube lumen 14 by the patency device 30. As mentioned, the pressure level of the impulses can be varied or determined according to a variety of factors, including catheter length, catheter lumen size, burst strength, impulse duration, rest period duration, other catheter configuration, etc. In one embodiment, the pressure of each impulse can be chosen from a range of from about 30 psi to about 120 psi, though other pressure below and above this are possible. Also, frequency of the impulses, or impulse frequency, can be set according to a predetermined pattern and can vary according to a number of factors such as those described immediately above and can range in one embodiment from about 1 to over about 150 Hz, though other frequency ranges are also possible. In one embodiment, the impulse frequency is set to match the resonant frequency of the catheter 10 itself, thus enabling improved propagation of the impulses distally through the lumen 14. In one example, for instance, the resonant frequency of a 3 Fr single lumen catheter assembly was found to be about 30 Hz for catheter tube lengths of from about 35 cm to about 55 cm. The resonant frequency will vary according to a number of catheter characteristics. In one embodiment, for instance, resonant frequencies for various catheters vary from about 15 Hz to about 50 Hz, though other frequencies are possible.
In one embodiment, the impulse frequency is above about 20 KHz, thus performing as an ultrasound impulse signal to dislodge lumen occlusions or maintain lumen patency. These ultrasonic signals are of sufficient frequency, intensity, and duty cycle as to dislodge the occlusion(s) present in the lumen(s) 14. In one embodiment, the patency device 30 can include a an ultrasound module operably connectable to the luer connector 22 or extension leg of the catheter 10 and further includes an ultrasound transducer for providing ultrasonic impulses to the fluid-filled lumen 14. The patency device 30 can further include ports to enable fluids or other substances to be infused into or aspired from the catheter tube lumen(s) 14, such as antimicrobial agents, etc.
Note that the patency device 30 is either externally powered or can include its own power source, such as a battery. Note further that in one embodiment that the controller 170 can enable customization of the characteristics of the impulses, rest periods, baseline pressure, etc. by the user.
It is appreciated that periodic use of the patency devices described herein can also serve to prevent the formation of an occlusion by preventing initial adherence and growth of the occlusion in the first place, as mentioned herein. In one embodiment, the patency device is self-operating, thus serving as a passive solution to preventing occlusions.
Note that in one embodiment a pressure regulator can be employed to provide and/or maintain pressurized fluid in the patency device 30. Note also that it is appreciated that adjustments may be made to the pressure of the impulses to compensate for pressure loss/attenuation as a function of the distance the impulse travels distally through the catheter tube lumen 14.
In light of the above, it is appreciated that in one embodiment, a method for providing patency to at the lumen(s) 14 the catheter assembly 10 comprises disposing a fluid in the lumen of the catheter tube 12 of the catheter; and propagating a plurality of impulses of positive pressure through the fluid disposed in the lumen, noting that the impulses are propagated in a predetermined pattern.
The patency device of
The valve 210 is operable, such as by 170 controller, to selectively open to enable the impulses produced by the aforementioned components to pass through to the catheter lumen 14. At all other times during a patency procedure, the valve 210 is switched to enable a negative baseline pressure to be imparted to the catheter lumen 14 via the syringe pump 162 in manner similar to embodiments discussed above. In one embodiment, pressure of the impulses produced by the patency device 30 of
A piston, such as a plunger, is operably connected to the movable cone of the loudspeaker of the wave generator 220 is received within the fluid-containing syringe 206, serving as the fluid reservoir 34. Operation of the loudspeaker moves the cone thereof in accordance with the driving signals received and amplified by the signal generator 224 and amplifier 226, which in turn moves the plunger in accordance with the driving signals. The fluid contained in syringe 106 is moved by the plunger, which produces the desired fluid impulses that are propagated distally through the lumen 14 of the catheter 10 via the hub adapter 208. In one embodiment, the impulses produced by the patency device of
The embodiments of the patency device 30 shown and described in connection with
In
In
Embodiments of the invention may be embodied in other specific forms without departing from the spirit of the present disclosure. The described embodiments are to be considered in all respects only as illustrative, not restrictive. The scope of the embodiments is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
This application is a continuation of U.S. patent application Ser. No. 15/619,219, filed Jun. 9, 2017, now U.S. Pat. No. 10,322,230, which claims the benefit of U.S. Provisional Application No. 62/348,082, filed Jun. 9, 2016, and titled “Systems and Methods for Correcting and Preventing Occlusion in a Catheter,” each of which is incorporated by reference in its entirety into this application.
Number | Name | Date | Kind |
---|---|---|---|
3941122 | Jones | Mar 1976 | A |
4155362 | Jess | May 1979 | A |
4191184 | Carlisle | Mar 1980 | A |
4446867 | Leveen et al. | May 1984 | A |
4551041 | Coon et al. | Nov 1985 | A |
4692139 | Stiles | Sep 1987 | A |
4698058 | Greenfeld et al. | Oct 1987 | A |
4781677 | Wilcox | Nov 1988 | A |
4808153 | Parisi | Feb 1989 | A |
4870953 | DonMicheal et al. | Oct 1989 | A |
4929242 | Desecki et al. | May 1990 | A |
4959050 | Bobo, Jr. | Sep 1990 | A |
5006304 | Franklin et al. | Apr 1991 | A |
5267565 | Beard | Dec 1993 | A |
5269291 | Carter | Dec 1993 | A |
5273027 | Sekino et al. | Dec 1993 | A |
5318014 | Carter | Jun 1994 | A |
5354273 | Hagen | Oct 1994 | A |
5427118 | Nita et al. | Jun 1995 | A |
5431663 | Carter | Jul 1995 | A |
5480379 | La Rosa | Jan 1996 | A |
5536242 | Willard et al. | Jul 1996 | A |
5592866 | Sher | Jan 1997 | A |
5807343 | Tucker | Sep 1998 | A |
5916192 | Nita et al. | Jun 1999 | A |
5925016 | Chornenky et al. | Jul 1999 | A |
5935146 | McEwen et al. | Aug 1999 | A |
6001069 | Tachibana et al. | Dec 1999 | A |
6007514 | Nita | Dec 1999 | A |
6024718 | Chen et al. | Feb 2000 | A |
6027450 | Brown et al. | Feb 2000 | A |
6126619 | Peterson et al. | Oct 2000 | A |
6135977 | Drasler et al. | Oct 2000 | A |
6142987 | Tsugita | Nov 2000 | A |
6149596 | Bancroft | Nov 2000 | A |
6210404 | Shadduck | Apr 2001 | B1 |
6371928 | Mcfann et al. | Apr 2002 | B1 |
6398714 | Verkerke et al. | Jun 2002 | B1 |
6433464 | Jones | Aug 2002 | B2 |
6435189 | Lewis et al. | Aug 2002 | B1 |
6471689 | Joseph et al. | Oct 2002 | B1 |
6602264 | McGuckin, Jr. | Aug 2003 | B1 |
6617760 | Peterson et al. | Sep 2003 | B1 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6676637 | Bonnette et al. | Jan 2004 | B1 |
6685657 | Jones | Feb 2004 | B2 |
6689109 | Lynn | Feb 2004 | B2 |
6723064 | Babaev | Apr 2004 | B2 |
6740059 | Flaherty | May 2004 | B2 |
6852097 | Fulton, III | Feb 2005 | B1 |
6855123 | Nita | Feb 2005 | B2 |
6921371 | Wilson | Jul 2005 | B2 |
6945951 | Bonnette et al. | Sep 2005 | B1 |
6979293 | Hansmann et al. | Dec 2005 | B2 |
7144381 | Gertner | Dec 2006 | B2 |
7220233 | Nita et al. | May 2007 | B2 |
7220239 | Wilson et al. | May 2007 | B2 |
7255690 | Gray et al. | Aug 2007 | B2 |
7297131 | Nita | Nov 2007 | B2 |
7335180 | Nita et al. | Feb 2008 | B2 |
7341569 | Soltani et al. | Mar 2008 | B2 |
7393338 | Nita | Jul 2008 | B2 |
7648478 | Soltani et al. | Jan 2010 | B2 |
7686825 | Hauser et al. | Mar 2010 | B2 |
7717853 | Nita | May 2010 | B2 |
7789830 | Ishida et al. | Sep 2010 | B2 |
7828762 | Wilson et al. | Nov 2010 | B2 |
7918822 | Kumar et al. | Apr 2011 | B2 |
7955293 | Nita et al. | Jun 2011 | B2 |
7993308 | Rule et al. | Aug 2011 | B2 |
7998121 | Stringham | Aug 2011 | B2 |
8043251 | Nita et al. | Oct 2011 | B2 |
8052704 | Olson | Nov 2011 | B2 |
8062316 | Patel et al. | Nov 2011 | B2 |
8083707 | Tosaya et al. | Dec 2011 | B2 |
8152753 | Nita et al. | Apr 2012 | B2 |
8162924 | Boyden et al. | Apr 2012 | B2 |
8167831 | Wilson et al. | May 2012 | B2 |
8317770 | Miesel et al. | Nov 2012 | B2 |
8348880 | Messerly et al. | Jan 2013 | B2 |
8366620 | Nita | Feb 2013 | B2 |
8414569 | Manwaring et al. | Apr 2013 | B2 |
8435225 | Courtney | May 2013 | B2 |
8617096 | Nita et al. | Dec 2013 | B2 |
8622911 | Hossack et al. | Jan 2014 | B2 |
8632560 | Pal et al. | Jan 2014 | B2 |
8647293 | Nita | Feb 2014 | B2 |
8758519 | Waldmann et al. | Jun 2014 | B2 |
8827953 | Rocha-Singh | Sep 2014 | B2 |
8852166 | Keilman et al. | Oct 2014 | B1 |
8876795 | Fiering et al. | Nov 2014 | B2 |
8956386 | Hauser et al. | Feb 2015 | B2 |
8999070 | MacKenzie | Apr 2015 | B2 |
9028748 | Zumeris et al. | May 2015 | B2 |
9107590 | Hansmann et al. | Aug 2015 | B2 |
9144693 | Appelman et al. | Sep 2015 | B2 |
9198680 | Fraser et al. | Dec 2015 | B2 |
9254144 | Nguyen et al. | Feb 2016 | B2 |
10245401 | Cuevas | Apr 2019 | B2 |
10322230 | Ofek et al. | Jun 2019 | B2 |
20020151825 | Rubenchik et al. | Oct 2002 | A1 |
20040019318 | Wilson et al. | Jan 2004 | A1 |
20040210140 | Rabiner et al. | Oct 2004 | A1 |
20050027265 | Maki et al. | Feb 2005 | A1 |
20050209578 | Christian Evans et al. | Sep 2005 | A1 |
20050215942 | Abrahamson et al. | Sep 2005 | A1 |
20050220711 | Katz | Oct 2005 | A1 |
20060173387 | Hansmann et al. | Aug 2006 | A1 |
20060241524 | Lee et al. | Oct 2006 | A1 |
20060264809 | Hansmann et al. | Nov 2006 | A1 |
20070167798 | Cai et al. | Jul 2007 | A1 |
20070213681 | Manna et al. | Sep 2007 | A1 |
20070239027 | Nita | Oct 2007 | A1 |
20070265560 | Soltani et al. | Nov 2007 | A1 |
20080097206 | Chomas et al. | Apr 2008 | A1 |
20080125657 | Chomas et al. | May 2008 | A1 |
20080243153 | Nguyen et al. | Oct 2008 | A1 |
20090018472 | Soltani et al. | Jan 2009 | A1 |
20090088724 | Chebator et al. | Apr 2009 | A1 |
20090118663 | Rockley et al. | May 2009 | A1 |
20090157003 | Jones et al. | Jun 2009 | A1 |
20090177158 | Krumme | Jul 2009 | A1 |
20100004534 | Neer | Jan 2010 | A1 |
20100010393 | Duffy et al. | Jan 2010 | A1 |
20100076370 | Howlett | Mar 2010 | A1 |
20100094201 | Mallaby | Apr 2010 | A1 |
20100217276 | Garrison et al. | Aug 2010 | A1 |
20100249719 | Fojtik | Sep 2010 | A1 |
20100262215 | Gertner | Oct 2010 | A1 |
20100286708 | Rittman | Nov 2010 | A1 |
20110046522 | Chan et al. | Feb 2011 | A1 |
20110087147 | Garrison et al. | Apr 2011 | A1 |
20110112564 | Wolf | May 2011 | A1 |
20110144540 | Shen et al. | Jun 2011 | A1 |
20120059285 | Soltani et al. | Mar 2012 | A1 |
20120179073 | Nita | Jul 2012 | A1 |
20120232434 | Nita et al. | Sep 2012 | A1 |
20120232435 | Nita et al. | Sep 2012 | A1 |
20120232465 | Nita et al. | Sep 2012 | A1 |
20120238916 | Nita et al. | Sep 2012 | A1 |
20120238946 | Nita et al. | Sep 2012 | A1 |
20120289889 | Genstler et al. | Nov 2012 | A1 |
20130116603 | Nita | May 2013 | A1 |
20130138082 | Salahieh | May 2013 | A1 |
20130331738 | Borrelli | Dec 2013 | A1 |
20140107481 | Wulfman | Apr 2014 | A1 |
20140155922 | Nita | Jun 2014 | A1 |
20150025543 | Nita et al. | Jan 2015 | A1 |
20150025544 | Nita et al. | Jan 2015 | A1 |
20150094595 | Havel et al. | Apr 2015 | A1 |
20150141817 | Chen et al. | May 2015 | A1 |
20150190660 | Sarge et al. | Jul 2015 | A1 |
20150196309 | Matsubara et al. | Jul 2015 | A1 |
20150320432 | Adams | Nov 2015 | A1 |
20150352379 | Appelman et al. | Dec 2015 | A1 |
20170354777 | Ofek et al. | Dec 2017 | A1 |
Number | Date | Country |
---|---|---|
9211891 | Jul 1992 | WO |
2014043650 | Mar 2014 | WO |
14149648 | Sep 2014 | WO |
14151209 | Sep 2014 | WO |
15029039 | Mar 2015 | WO |
2015074032 | May 2015 | WO |
15157330 | Oct 2015 | WO |
2017214573 | Dec 2017 | WO |
Entry |
---|
EP 17811123.3 filed Jan. 9, 2019 Extended European Search Report dated Jan. 13, 2020. |
Atar S, Neuman Y, Miyamoto T, Chen M, Birnbaum Y, Luo H, Kobal S, Siegel RJ. “Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.” J Thromb Thrombolysis. Jun. 2003; 15(3):165-9. |
Doomernik DE, Schrijver AM, Zeebregts CJ, de Vries JP, Reijnen MM. “Advancements in catheter-directed ultrasound-accelerated thrombolysis.” J Endovasc Ther. Jun. 2011; 18(3):418-34. |
EKOS EkoSonic Ultrasound Endovascular System—designed to treat intravascular clots using ultrasound technology https://www.btg-im.com/en-US/EKOS/Products/EkoSonic-EndoVascular-System, last accessed Jun. 9, 2017. |
Emmi-dent—Ultrasound emitting oral toothbrush designed to prevent biofilm formation and remove bacteria on teeth (http://www.emmi-dent.com) Last accessed Jun. 9, 2017. |
Joyce E, Phull SS, Lorimer JP, Mason T J. “The development and evaluation of ultrasound for the treatment of bacterial suspensions. A study of frequency, power and sonication time on cultured Bacillus species.” Ultrason Sonochem. 2003. |
Mason T J, Joyce E, Phull SS, Lorimer JP. “Potential uses of ultrasound in the biological decontamination of water.” Ultrason Sonochem. Oct. 2003;10(6):319-23. |
Mourad PD, Roberts FA, Mcinnes C. “Synergistic use of ultrasound and sonic motion for removal of dental plaque bacteria.” Compend Contin Educ Dent. Jul. 2007;28(7):354-8. |
Neuman Y, Rukshin V, Tsang V, Atar S, Miyamoto T, Luo H, Kobal S, Thompson T, Birnbaum Y, Horzewski M, Siegel RJ, Kaul S. “Augmentation of in-stent clot dissolution by low frequency ultrasound combined with aspirin and heparin. An exvivo canine shunt study.” Thromb Res. 2003;112(1-2):99-104. |
Owens CA. “Ultrasound-Enhanced Thrombolysis: EKOS EndoWave Infusion Catheter System.” Seminars in Interventional Radiology. 2008;25(1):37-41. |
Pajek D, Burgess A, Huang Y, Hynynen K. “High-intensity focused ultrasound sonothrombolysis: the use of perfluorocarbon droplets to achieve clot lysis at reduced acoustic power.” Ultrasound Med Biol. Sep. 2014;40 (9):2151-61. |
U.S. Appl. No. 15/619,219, filed Jun. 9, 2017 Non-Final Office Action dated Jul. 26, 2018. |
U.S. Appl. No. 15/619,219, filed Jun. 9, 2017 Notice of Allowance dated Feb. 8, 2019. |
Wright C, Hynynen K, Goertz D. “In vitro and in vivo high-intensity focused ultrasound thrombolysis.” Invest Radial. Apr. 2012;47(4):217-25. |
PCT/US2017/036866 filed Jun. 9, 2017, International Search Report and Written Opinion dated Aug. 16, 2017. |
Number | Date | Country | |
---|---|---|---|
20190290838 A1 | Sep 2019 | US |
Number | Date | Country | |
---|---|---|---|
62348082 | Jun 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15619219 | Jun 2017 | US |
Child | 16436726 | US |